Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing prevalence of chronic diseases across the U.S.
3.2.1.2 Rising technological advancements in nuclear medicine
3.2.1.3 Rise in healthcare expenditure
3.2.1.4 Favorable government initiatives
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of radiotherapy
3.2.2.2 Short half-life of radiopharmaceuticals
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.5.1 Core technologies
3.5.2 Adjacent technologies
3.6 Future market trends
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Diagnostics
5.2.1 Single photon emission computed tomography (SPECT) isotopes
5.2.1.1. TC-99 m
5.2.1.2 I-123
5.2.1.3 GA-67
5.2.1.4 TL-201
5.2.1.5 Other SPECT isotopes
5.2.2 Positron emission tomography (PET) isotopes
5.2.2.1 F-18
5.2.2.2 RB-82
5.2.2.3 Other PET isotopes
5.3 Therapeutics
5.3.1 Beta emitters
5.3.1.1 I-131
5.3.1.2 Lu-177
5.3.1.3 Y-90
5.3.1.4 SM-153
5.3.1.5 Re-186
5.3.1.6 Other beta emitters
5.3.2 Brachytherapy isotopes
5.3.2.1 Iridium-192
5.3.2.2 Iodine-125
5.3.2.3 Cesium-131
5.3.2.4 Palladium-103
5.3.2.5 Other brachytherapy isotopes
5.3.3 Alpha emitters
5.3.3.1 RA-223
5.3.3.2 Other alpha emitters
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Neurology
6.3 Cardiology
6.4 Oncology
6.5 Thyroid
6.6 Pulmonary
6.7 Other applications
Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Diagnostic centres
7.4 Research institutes
7.5 Other end users
Chapter 8 Market Estimates and Forecast, By Zone, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 East North Central
8.3 West South Central
8.4 South Atlantic
8.5 Northeast
8.6 East South Central
8.7 West North Central
8.8 Pacific Central
8.9 Mountain States
Chapter 9 Company Profiles
9.1 Actinium Pharmaceuticals
9.2 Best Medical International
9.3 Boston Scientific Corporation
9.4 Bracco
9.5 Cardinal Health
9.6 Curium Pharma
9.7 GE Healthcare
9.8 GT Medical Technologies
9.9 Iso-Tex Diagnostics
9.10 ITM Isotope Technologies
9.11 Jubilant Pharma
9.12 Lantheus
9.13 Novartis
9.14 RadioMedix
9.15 RLS Radiopharmacies
9.16 Siemens Healthineers
9.17 Sirtex
9.18 Sun Pharmaceutical Industries
9.19 Theragenics Corporation
